Перегляд зібрання за групою - Автори Korol, L.

Перейти до: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я І Ї Є
або ж введіть декілька перших літер:  
Результати 1 до 15 із 15
Дата випускуНазваАвтор(и)
2021A potential role of fecal oxalate-degrading activity in oxalate homeostasis in end-stage renal disease patients; a descriptive pilot studyStepanova, N.; Tolstanova, G.; Korol, L.; Akulenko, I.; Savchenko, O.; Kolesnyk, M.
2018Antioxidant effects of immunomodulators in patients with recurrent pyelonephritisKolesnyk, M.; Korol, L.; Stepanova, N.; Driianska, V.; Migal, L.; Savchenko, V.
2019-03Can hyperoxaluria cause kidney damage in women with recurrent pyelonephritis?Stepanova, N.; Kolesnyk, M.; Driianska, V.; Korol, L.
2021Could the residual renal function remain a key determinant of plasma oxalic acid concentration in peritoneal dialysis patients?Stepanova, N.; Korol, L.; Snisar, L.; Lebid, L.
2019Extracellular overhydration in peritoneal dialysis patients linked with increased oxidative stressStepanova, N.; Korol, L.; Burdeyna, O.; Kolesnyk, M.
2022Low Oxalate-Degrading Activity in Fecal Microbiota is Associated With High Serum Indoxyl Sulfate and Plasma Oxalic Acid Concentrations in Dialysis PatientsStepanova, N.; Korol, L.; Tolstanova, G.; Akulenko, I.
2022Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related PeritonitisStepanova, N.; Korol, L.; Lebid, L.; Snisar, L.; Savchenko, S.
2019Oxidative status in hemodialysis patients with erythropoietin hyporesponsiveness anemiaKorol, L.; Stepanova, N.; Novakisksiy, V.; Shifris, I.; Migal, L.
2019Oxidative stress in peritoneal dialysis patients: association with the dialysis adequacy and technique survivalStepanova, N.; Korol, L.; Burdeyna, O.
2021Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot studyStepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L.
2020Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot studyStepanova, N.; Driianska, V.; Korol, L.; Snisar, L.; Lebed, L.
2020Regulation of oxalate homeostasis by oxalate-degrading activity in fecal microbiota in dialysis patientsStepanova, N.; Tolstanova, G.; Akulenko, I.; Korol, L.; Savchenko, O.; Snisar, L.; Kolesnyk, M.
2020Serum paraoxonase 1 arylesterase activity as an antioxidant marker in dialysis patientsKorol, L.; Stepanova, N.; Vasylchenko, V.
2022Serum total indoxyl sulfate is associated with intraperitoneal inflammation and high peritonitis episodes in peritoneal dialysis patientsStepanova, N.; Korol, L.; Driianska, V.; Snisar, L.; Lebid, L.; Kompaniets, O.
2018The relationship between the dose of continuous erythropoietin receptor activator and oxidative stress in hemodialysis patientsStepanova, N.; Korol, L.; Novakivskyy, V.; Kolesnyk, M.